Literature DB >> 10584889

A cost-effectiveness analysis of a residential radon remediation programme in the United Kingdom.

C A Kennedy1, A M Gray, A R Denman, P S Phillips.   

Abstract

As residential radon programmes of identification and remediation have proceeded, so questions have been raised about their costs and benefits. This study presents a generalizable model for estimating the cost-effectiveness of a radon mitigation programme using the methodological framework now considered appropriate in the economic evaluation of health interventions. Its use will help to inform future discussion of radon remediation and lung cancer prevention programmes. Data from Northamptonshire were analysed, resulting in a societal cost-effectiveness ratio of Pounds Sterling 13250 per life-year gained in 1997. The percentage of houses found to be over the action level, and the percentage of householders who decide to remediate are shown to be important parameters for the cost-effectiveness analysis. Questions are raised about the particular importance of perspective in this type of analysis and suggestions are made for future research directions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10584889      PMCID: PMC2374336          DOI: 10.1038/sj.bjc.6690836

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  8 in total

1.  Regulatory control of indoor Rn.

Authors:  K L Mossman; M A Sollitto
Journal:  Health Phys       Date:  1991-02       Impact factor: 1.316

2.  A review of the cost effectiveness of radon mitigation in domestic properties in Northamptonshire.

Authors:  A R Denman; P S Phillips
Journal:  J Radiol Prot       Date:  1998-06       Impact factor: 1.394

3.  The costs of treating breast cancer in the United Kingdom: implications for screening.

Authors:  J L Wolstenholme; S J Smith; D K Whynes
Journal:  Int J Technol Assess Health Care       Date:  1998       Impact factor: 2.188

4.  Radon: a human carcinogen.

Authors:  P S Phillips; A R Denman
Journal:  Sci Prog       Date:  1997       Impact factor: 2.774

5.  Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.

Authors:  M Johannesson; B Jönsson; J Kjekshus; A G Olsson; T R Pedersen; H Wedel
Journal:  N Engl J Med       Date:  1997-01-30       Impact factor: 91.245

6.  Reducing the risks from radon.

Authors:  F Marcinowski; S Napolitano
Journal:  Air Waste       Date:  1993-07

Review 7.  Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis.

Authors:  A Briggs; M Sculpher; M Buxton
Journal:  Health Econ       Date:  1994 Mar-Apr       Impact factor: 3.046

8.  Risk of lung cancer associated with residential radon exposure in south-west England: a case-control study.

Authors:  S Darby; E Whitley; P Silcocks; B Thakrar; M Green; P Lomas; J Miles; G Reeves; T Fearn; R Doll
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

  8 in total
  2 in total

1.  Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them.

Authors:  Alastair Gray; Simon Read; Paul McGale; Sarah Darby
Journal:  BMJ       Date:  2009-01-06

2.  Cost Effectiveness of Environmental Lead Risk Mitigation in Low- and Middle-Income Countries.

Authors:  Bret Ericson; Jack Caravanos; Conrado Depratt; Cynthia Santos; Mishelle Gomez Cabral; Richard Fuller; Mark Patrick Taylor
Journal:  Geohealth       Date:  2018-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.